Patents by Inventor Chan Woong Park

Chan Woong Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11219653
    Abstract: The specification relates to a composition for enhancing immunity, comprising a ginseng berry polysaccharide as an active ingredient. The composition can increase the expression of cytokines such as IL-6, IL-12, and TNF-? by using ingredients derived from natural products. In addition, the composition can exhibit excellent immunity enhancement effects because of the unique components and structure of a ginseng berry polysaccharide.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: January 11, 2022
    Assignees: AMOREPACIFIC CORPORATION, KYONGGI UNIVERSITY INDUSTRY & ACADEMIA COOPERATION FOUNDATION 1
    Inventors: Suhwan Kim, Juewon Kim, Chan-woong Park, Dae Bang Seo, Donghyun Cho, Kwang Soon Shin, Dae Young Lee
  • Publication number: 20210298339
    Abstract: The present disclosure relates to an emulsion composition containing ginseng seed oil and ginseng berry extract, wherein the composition is a single phase. Whereas the existing composition containing a water-soluble ingredient as a main ingredient has the problem that, when ginseng seed oil is added, formulation stability is decreased as the ginseng seed oil is separated from the water-soluble ingredient, the emulsion composition according to the present disclosure exhibits superior stability because the ginseng seed oil is uniformly mixed with the water-soluble ingredient and separation of the ginseng seed oil from the water-soluble ingredient does not occur fora long period of time.
    Type: Application
    Filed: March 30, 2021
    Publication date: September 30, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Su Hwan KIM, Sangyoul NA, Hyun Woo JEONG, Wanki KIM, Jisung KIM, Chan Woong PARK
  • Publication number: 20210267242
    Abstract: One aspect of the present disclosure relates to a granular composition containing sugar alcohols and a method for preparing the same. More specifically, according to one aspect of the present disclosure, a granular composition having a particle size of 12 mesh to 60 mesh may be prepared by introducing raw materials containing a high content of sugar alcohols containing (i) xylitol and (ii) erythritol, mannitol or a combination thereof to an extrusion molding granular, and the granular composition has a softly melting texture and has an excellent effect in user's preference and convenience in ingestion.
    Type: Application
    Filed: February 2, 2021
    Publication date: September 2, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Sukyung Kim, Juyeon Seo, Jinoh Chung, Wanki Kim, Chan Woong Park, Jaehyun Kim, Hyoseung Lee
  • Patent number: 11096921
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: August 24, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20210196776
    Abstract: Disclosed is a composition for preventing or inhibiting influenza virus infection, containing ginseng berry polysaccharides as active ingredients, and the ginseng berry polysaccharides exhibit an inhibitory effect on influenza virus activity or infection due to specific ingredients and structures and, specifically, have an excellent inhibitory effect on neuraminidase activity.
    Type: Application
    Filed: April 26, 2019
    Publication date: July 1, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Donghyun CHO, Suhwan KIM, Juewon KIM, Chan Woong PARK, Dae Bang SEO
  • Publication number: 20210128660
    Abstract: The specification relates to a composition for enhancing immunity, comprising a ginseng berry polysaccharide as an active ingredient. The composition can increase the expression of cytokines such as IL-6, IL-12, and TNF-? by using ingredients derived from natural products. In addition, the composition can exhibit excellent immunity enhancement effects because of the unique components and structure of a ginseng berry polysaccharide.
    Type: Application
    Filed: January 26, 2018
    Publication date: May 6, 2021
    Inventors: Suhwan KIM, Juewon KIM, Chan-woong PARK, Dae Bang SEO, Donghyun CHO, Kwang Soon SHIN, Dae Young LEE
  • Patent number: 10898535
    Abstract: The present invention relates to a composition for inhibiting and preventing myopathy comprising a bean leaf extract as an active ingredient. More specifically, the composition has an effect of inhibiting the overexpression of Atrogin1 and Murf1 specifically expressed in myocyte and restoring cell activity of myocyte to inhibit and prevent muscle loss by including the extract of bean leaf at stage R6 to R8 during the growth stage of bean.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: January 26, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Young-Gyu Kang, Soo Hyun Kim, Chan Woong Park, Hee Young Jeon
  • Patent number: 10891401
    Abstract: Disclosed is a mobile terminal having a security function. The mobile terminal having a security function according to the present invention comprises: a case unit having a keypad for inputting data; a substrate unit, disposed inside the case unit, having a data input switch part operated by a keypad; and a tamper-resistant unit, disposed between a keypad and the data input switch part, having a tamper-proof conductive track part electrically connected to the substrate unit, wherein the tamper-proof unit includes a switch shielding part for shielding the data input switch part, and a connecting part for connection, connected to the switch shielding part and electrically connected to the substrate unit.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: January 12, 2021
    Assignee: BLUEBIRD INC.
    Inventors: Jang Won Lee, Moon Gyu Hong, Chan Woong Park
  • Patent number: 10692649
    Abstract: A switching power supply device which includes an input filter capacitor and a switching device, includes: a transformer comprising a core of the transformer and a first input winding, the first input winding being wound around the core of the transformer, connected between one terminal of the input filter capacitor and one terminal of the switching device; a first capacitive unit connected between both terminals of the first attenuation winding part of the transformer, and including at least one device including a first capacitor; and a clamp unit configured to limit a peak voltage generated by the first input winding when the switching device is turned off during the switching operation of the switching device, the clamp unit including a rectification diode.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: June 23, 2020
    Inventor: Chan Woong Park
  • Patent number: 10555983
    Abstract: Provided in the present specification is a composition for brain activation, comprising ginseng fruit extract as an active ingredient. The composition according to the present specification allows an increase in blood flow in the brain and thus has an effect of ameliorating chronic fatigue syndrome. In addition, the composition according to the present specification activates the brain, and as a result, strengthens connectivity strength between the frontal lobe and the occipital lobe and thus has an effect of improving problem-solving accuracy and reducing solving time in the area of cognitive ability. Therefore, the composition according to the present specification can be used as a pharmaceutical composition or a food composition for patients suffering from chronic fatigue syndrome.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: February 11, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung Shin, Chan Woong Park, Su Hwan Kim, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20200000867
    Abstract: The present invention relates to a composition for inhibiting and preventing myopathy comprising a bean leaf extract as an active ingredient. More specifically, the composition has an effect of inhibiting the overexpression of Atrogin1 and Murf1 specifically expressed in myocyte and restoring cell activity of myocyte to inhibit and prevent muscle loss by including the extract of bean leaf at stage R6 to R8 during the growth stage of bean.
    Type: Application
    Filed: September 11, 2019
    Publication date: January 2, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Young-Gyu Kang, Soo Hyun Kim, Chan Woong Park, Hee Young Jeon
  • Patent number: 10383904
    Abstract: The present invention relates to a composition which improves the quality of life of women by containing a ginseng berry extract as an active ingredient, and more specifically, to a composition which promotes the general psychological and physical health of women and improving the sexual function and sex life satisfaction women.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: August 20, 2019
    Assignee: Amorepacific Corporation
    Inventors: Chan Woong Park, Su Hwan Kim, Jeong Hwa Jang, Hyun Jung Shin, Sun Mi Kim, Wan Gi Kim, Sang Jun Lee
  • Patent number: 10342836
    Abstract: The present disclosure relates to a composition containing ginseng fruit extract. The present disclosure also relates to a composition for relieving premenstrual syndrome and menstrual pain, which contains ginseng fruit extract. The composition according to the present disclosure exhibits an effect of relieving or improving the symptoms of premenstrual syndrome and thus can be used as a pharmaceutical composition or a food composition.
    Type: Grant
    Filed: June 19, 2014
    Date of Patent: July 9, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su Hwan Kim, Chan Woong Park, Jeong Hwa Jang, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20190122008
    Abstract: Disclosed is a mobile terminal having a security function. The mobile terminal having a security function according to the present invention comprises: a case unit having a keypad for inputting data; a substrate unit, disposed inside the case unit, having a data input switch part operated by a keypad; and a tamper-resistant unit, disposed between a keypad and the data input switch part, having a tamper-proof conductive track part electrically connected to the substrate unit, wherein the tamper-proof unit includes a switch shielding part for shielding the data input switch part, and a connecting part for connection, connected to the switch shielding part and electrically connected to the substrate unit.
    Type: Application
    Filed: March 7, 2016
    Publication date: April 25, 2019
    Applicant: BLUEBIRD INC.
    Inventors: Jang Won LEE, Moon Gyu HONG, Chan Woong PARK
  • Publication number: 20190074132
    Abstract: A switching power supply device which includes an input filter capacitor and a switching device, includes: a transformer comprising a core of the transformer and a first input winding, the first input winding being wound around the core of the transformer, connected between one terminal of the input filter capacitor and one terminal of the switching device; a first capacitive unit connected between both terminals of the first attenuation winding part of the transformer, and including at least one device including a first capacitor; and a clamp unit configured to limit a peak voltage generated by the first input winding when the switching device is turned off during the switching operation of the switching device, the clamp unit including a rectification diode.
    Type: Application
    Filed: March 16, 2017
    Publication date: March 7, 2019
    Inventor: Chan Woong PARK
  • Patent number: 10172900
    Abstract: The present invention relates to a ginseng mixed composition with improved bioavailability of saponin. Further, the present invention relates to a method for improving saponin bioavailability of a subject comprising: administering to the subject an effective amount of at least one extract selected from a Schizandra chinensis extract and a Liriope platyphylla extract that improves saponin bioavailability in the subject.
    Type: Grant
    Filed: May 25, 2010
    Date of Patent: January 8, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hee Young Jeon, Ji Hae Lee, Kyung Mi Joo, Chan Woong Park, Kyung Min Lim, Dae Bang Seo, Sang Jun Lee
  • Patent number: 10086028
    Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: October 2, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Chan-Woong Park, Myeong Hoon Yeom, Nam Hoon Cho, Sang Jun Lee, Sang Min Lee, Jin Young Lee, Hee Yong Jeon, Young-Myeong Kim, Chun-Ki Kim, Young Deuk Choi
  • Patent number: 10022351
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: July 17, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20180169166
    Abstract: The present invention relates to a composition for inhibiting and preventing myopathy having a bean leaf extract as an active ingredient. The composition has an effect of inhibiting the overexpression of Atrogin1 and Murf1 specifically expressed in myocyte and restoring cell activity of myocyte to inhibit and prevent muscle loss by including the extract of bean leaf at stage R6 to R8 during the growth stage of bean.
    Type: Application
    Filed: May 9, 2016
    Publication date: June 21, 2018
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu KIM, Young-Gyu KANG, Soo Hyun KIM, Chan Woong PARK, Hee Young JEON
  • Patent number: 9999611
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: June 19, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee